Source - SMW
Directa Plus, a producer and supplier of graphene-based products for use in consumer and industrial markets,says  Ufficio Brevetti e Marchi (Italian Patent and Trademark Office) has issued notification that a further two patents have been granted covering Directa Plus's proprietary G+ manufacturing process. 

The company now has a portfolio of 14 patents granted and eight pending.   Patent MI2014A001123: Process for preparing graphene nanoplatelets (GNPs)  This patent covers the core of Directa Plus's G+ technology, the liquid exfoliation phase, where the company's material passes from a 3D to 2D state.   Patent MI2014A001124L: Continuous process for preparing pristine GNPs This patent covers the entire production process of G+ pristine GNPs, which comprises natural graphite expansion, exfoliation and drying to obtain different grades and physical forms of G+ materials.   The patent is focused on the continuous character of the process while maintaining its inherent flexibility for the production of customised graphene-based products. 

The whole production process does not involve the use of any type of chemistry nor oxidation steps, therefore providing pure materials already certified as non-toxic for human health.

Related Charts

Directa Plus (DCTA)

+2.50p (+2.22%)
delayed 18:15PM